t
| Date | 4 Sept 2026 |
| Time | 11:00:00 |
| Category | Holding(s) in Company |
| ID | nsm:17a0be89-cbf7-46fe-b571-d591d770bf06.html |
Disseminated via PRN on 4 September 2026
Faron Pharmaceuticals
04 Sep 2026 10:00 UTC
Faron Pharmaceuticals Ltd | Company announcement | September 04, 2026 at 13:00:00 EEST
Standard form for notification of major holdings
| NOTIFICATION OF MAJOR HOLDINGS | ||||||
|
|
||||||
| 1a. Identity of the issuer or the underlying issuer of existing shares: | Faron Pharmaceuticals Oy | |||||
| 1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate) | ||||||
| Non-UK issuer | X | |||||
| 2. Reason for the notification (please mark the appropriate box or boxes with an “X”) | ||||||
| An acquisition or disposal of shares |
|
|||||
| An acquisition or disposal of financial instruments | X | |||||
| An event changing the breakdown of shares outstanding |
|
|||||
| Other (please specify): |
|
|||||
| 3. Details of person subject to the notification obligation | ||||||
| Name | Pentwater Capital Management LP | |||||
| City and country of registered office (if applicable) | Naples, United States | |||||
| 4. Full name of shareholder(s) (if different from 3.) | ||||||
| Name |
|
|||||
| City and country of registered office (if applicable) |
|
|||||
| 5. Date on which the threshold was crossed or reached: | 01/09/2026 | |||||
| 6. Date on which issuer notified (DD/MM/YYYY): | 02/09/2026 | |||||
| 7. Total positions of person(s) subject to the notification obligation | ||||||
|
|
% of shares outstanding (total of 8. A) | % of shares outstanding through financial instruments
(total of 8.B 1 + 8.B 2) |
Total of both in % (8.A + 8.B) | Total number of shares outstanding held in issuer | ||
| Resulting situation on the date on which threshold was crossed or reached |
|
Less than 3% | Less than 3% |
|
||
| Position of previous notification (if
applicable) |
|
3.875746% | 3.875746% |
|
||
| 8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedv | ||||
| A: Shares | ||||
| Class/type of
shares ISIN code (if possible) |
Number of shares outstanding | % of shares outstanding | ||
| Direct
|
Indirect
|
Direct
|
Indirect
|
|
|
|
|
|
|
|
| SUBTOTAL 8. A |
|
|
||
| B 1: Financial Instruments as an entitlement to acquire | ||||
| Type of financial instrument | Expiration
date |
Exercise/
Conversion Period |
Number shares that may be acquired if the instrument is
exercised/converted. |
% of shares outstanding |
|
|
|
|
|
|
|
|
|
SUBTOTAL 8. B 1 |
|
|
| B 2: Financial Instruments with similar economic effect | |||||
| Type of financial instrument | Expiration
date |
Exercise/
Conversion Period |
Physical or cash
settlement |
Number of shares | % of shares outstanding |
| Swap |
|
|
Cash Settlement | Less than 3% | Less than 3% |
|
|
|
|
|
|
|
|
|
|
|
SUBTOTAL 8.B.2 | Less than 3% | Less than 3% |
| 9. Information in relation to the person subject to the notification obligation (please mark the
applicable box with an “X”) |
||||
| Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer |
|
|||
| Full chain of controlled undertakings through which the shares and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity(please add additional rows as necessary) |
X | |||
| Name | % of shares outstanding if it equals or is higher than the notifiable threshold | % of shares outstanding through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold | |
| Matthew Halbower |
|
|
|
|
| MCH PWCM Holdings Inc. |
|
|
|
|
| Pentwater Capital Management LP |
|
Less than 3% | Less than 3% | |
|
|
||||
| 10. Additional information | ||||
|
|
||||
| Place of completion | Naples |
| Date of completion | 02/09/2026 |
MFN is a regulatory news distribution service and it is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. The service is built to easily manage all the tasks of news distribution for listed companies.
For further information, please contact [email protected] or visit Modular Finance.
View the source version on MFN: FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY